Home

Christopher Durant Turner, Chief Medical Officer: Nuvalent NUVL Sell · Filed 23/07/24

Trade details

Type
Insider sale
Amount
$9,364
Shares · price
200 sh · $46.82 a share
Held after
14,513 sh
Trade date
23/07/24
Filed
23/07/24
Days to filing
0 days

Sold 1.4% of holdings

Share of holding sold
1.4%

Nuvalent trades, last 26 weeks

What else happened in Nuvalent around then

Filed or reported within 30 days of the trade day · 23/06/24~23/08/23

Christopher Durant Turner's recent trades

Christopher Durant Turner, Chief Officer — sold $9,364 of Nuvalent NUVL · 1.4% of holdings · 10b5-1 plan | Whalegun